成大生物(688739.SH):控股股東將變更爲韶關高騰 2月13日起復牌
格隆匯2月12日丨成大生物(688739.SH)公佈,公司控股股東遼寧成大於2025年2月12日召開第十屆董事會第三十三次(臨時)會議,審議通過董事會換屆選舉相關議案,本次董事會換屆完成後,韶關高騰通過提名並當選董事人數超過遼寧成大董事會非獨立董事席位半數的方式,實現對遼寧成大經營管理產生重大影響。遼寧成大的控股股東將由遼寧國資經營公司變更爲韶關高騰,實際控制人將由遼寧國資委變更爲無實際控制人。
公司控股股東遼寧成大的控制權變動後,韶關高騰將通過遼寧成大間接控制公司54.67%股權。公司已收到韶關高騰就本次要約收購事宜出具的《遼寧成大生物股份有限公司要約收購報告書摘要》。本次控制權變更後,公司管理經營團隊不會發生較大變化。本次控制權變更不會對公司日常生產經營產生實質性影響,不存在損害公司及廣大投資者特別是中小股東利益的情形。本次控制權變更後,公司將繼續認真落實和推進既定發展戰略,增強核心競爭力,持續爲公司股東創造價值。經公司向上海證券交易所申請,公司股票將於2025年2月13日(星期四)開市起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.